Fatima Hussein
Verified
As seen in:
Associated Press,
MSN,
MSN Australia,
MSN Canada,
MSN Colombia,
MSN India,
MSN Ireland,
MSN Malaysia,
MSN Mexico,
MSN Money Canada,
MSN Philippines
and
Healthcare policy reporter @AP; Email fhussein@ap.org
Signal 202-436-5246
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Fatima Hussein
Trump’s $90 Medicare Part B rebate rolls out, but who’s eligible?
FILE – A Medicare Advantage PPO card rests on top of a Medicare card in Portland, Ore., June 10, 2024. (AP Photo/Jenny Kane, File) PUBLISHED: October 17, 2026 at 11:00 AM EDT President Donald Trump says his administration will make one-time payments of $90 per person to help more than 20 million Medicare enrollees pay for their Part B premiums. It will cost about $2 billion. Less than one-third of all Medicare recipients are eligible for the payments, which are expected to be sent out this week.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
A new Medicare season begins, but some shifts will arrive in 2027
A Medicare Advantage PPO card rests on top of a Medicare card in Portland, Ore., June 10, 2024. AP File Photo Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services,, left, and Health and Human Services Secretary Robert F. Kennedy Jr., right, listen as President Donald Trump speaks during an event about healthcare in the Oval Office of the White House, Friday Sept. 18, in Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
; ; ; Continuar leyendo Más para ti ; ; ; Continuar leyendo Más para ti
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
; ; ; Continuar leyendo Más para ti Continuar leyendo Más para ti
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
; ; ; Continuar leyendo Más para ti Continuar leyendo Más para ti
Trump increased investments in drugmakers benefitting from Medicare exemptions, Democrats say
Trump increased investments in drugmakers benefitting from Medicare exemptions, Democrats say
Social Security recipients to get 3.6% cost of living boost, an average of $75 per month
The Social Security Administration projected Wednesday that the annual cost-of-living adjustment for older adults and people with disabilities will go up by 3.6% beginning in 2027, with some recipients complaining that is not enough to offset soaring prices. The adjustment translates to $75 extra per month for the nearly 72 million people who receive monthly Social Security benefits and about 7.3 million beneficiaries who get Supplemental Security Income.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
; ; ; ; Continue reading More for You Continue reading More for You
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) â Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
WASHINGTON (AP) — Las inversiones en compañías farmacéuticas realizadas en nombre del presidente Donald Trump aumentaron significativamente tras su regreso a la Casa Blanca el año pasado, y su cartera sumó millones de dólares en acciones de empresas que se beneficiaron de una ley respaldada por los republicanos que protege a ciertos medicamentos de las negociaciones de precios de Medicare, según un informe presentado por los demócratas del Congreso.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
WASHINGTON (AP) — Las inversiones en compañías farmacéuticas realizadas en nombre del presidente Donald Trump aumentaron significativamente tras su regreso a la Casa Blanca el año pasado, y su cartera sumó millones de dólares en acciones de empresas que se beneficiaron de una ley respaldada por los republicanos que protege a ciertos medicamentos de las negociaciones de precios de Medicare, según un informe presentado por los demócratas del Congreso.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
El presidente de Estados Unidos, Donald Trump, habla en el Rosedal de la Casa Blanca en un evento para socorristas, el jueves 15 de octubre de 2026, en Washington.
Inversiones de Trump en farmacéuticas se dispararon tras su regreso a Washington, dicen demócratas
Encuestas recientes de The Associated Press y el NORC Center for Public Affairs Research muestran que la mayoría de los estadounidenses cree que Trump se beneficia de la presidencia de maneras poco éticas o ilegales y que está más centrado en su riqueza que en ayudar a personas como ellos.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) - Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
President Donald Trump speaks in the Rose Garden of the White House during an event for first responders Thursday, Oct. 15, in Washington.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
By FATIMA HUSSEIN Associated Press WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
By FATIMA HUSSEIN Associated Press WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
WASHINGTON (AP) — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Trump’s pharma holdings surged from $1.7 million in 2024 to $56.2 million as drugmakers gained Medicare exemptions, Democrats say
Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.
Show More
loading
Actions
Get in touch with Fatima
Contact Fatima, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack